Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Lactoferrin in COVID-19
NCT04475120Phase 3Completed
- Sponsor
- University of Rome Tor Vergata
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of lactoferrin in coronavirus disease 2019 (COVID-19), sponsored by University of Rome Tor Vergata. Started Apr 2020; status: completed.
02
Drugs
lactoferrin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04475120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475120.